Leaderboards/head and neck cancer studies

head and neck cancer studies

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Abhinav Thakral
Princess Margaret Cancer Centre
99
2
Osvaldo Espin‐Garcia
Western University
90
3
A. Dimitrios Colevas
Unknown
80
4
Sara I. Pai
Yale Cancer Center
70
5
Dan P. Zandberg
University of Pittsburgh
60
6
David I. Conway
Beatson West of Scotland Cancer Centre
40
7
Craig D. Smith
Beatson West of Scotland Cancer Centre
30
8
Alexander T. Pearson
University of Chicago
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Douglas E. Peterson
UConn Health
99
2
Kathy Taylor
Johannes Gutenberg University Mainz
90
3
A. Dimitrios Colevas
Unknown
80
4
Martina Recalde
Universitat Autònoma de Barcelona
70
5
Oğuz Kuşçu
Hacettepe University
60
6
Alexander T. Pearson
University of Chicago
50
7
Mohammad R. Salmanpour
Spinal Cord Injury BC
40
8
Zahra Mansouri
University Hospital of Geneva
30
9
Lin Gui
Chinese Academy of Medical Sciences & Peking Union Medical College
20
10
Dan P. Zandberg
UPMC Hillman Cancer Center
10

Emerging Leaders Papers

1
Intranasal CEPO-FC prevents attention deficits in streptozotocin-induced rat model of Alzheimer's disease: Focus on synaptic plasticity-related factors
PubMed|2023
2 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Arlene A. Forastiere
Johns Hopkins University
99
2
Lillian L. Siu
Princess Margaret Cancer Centre
90
3
Andreas Schalhorn
Unknown
80
4
Robert I. Haddad
Georgetown University
70
5
Everett E. Vokes
University of Chicago
60
6
Lester J. Peters
Peter MacCallum Cancer Centre
50
7
Harlan W. Waksal
Birmingham VA Medical Center
40
8
H. Cortés-Funes
Hospital Universitario Miguel Servet
30
9
S. Kaasa
St Olav's University Hospital
20
10
Charles C. Muscoplat
Harper University Hospital
10

All-Time Leaders Papers

1
Dose Escalation Methods in Phase I Cancer Clinical Trials
JNCI Journal of the National Cancer Institute|2009
856 cit.
2
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
495 cit.
3
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
JAMA Oncology|2020
340 cit.
4
Frameshift events predict anti–PD-1/L1 response in head and neck cancer
JCI Insight|2018
276 cit.
5
The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
Journal of Thoracic Oncology|2016
253 cit.
6
A Phase II Clinical and Pharmacodynamic Study of E7070 in Patients with Metastatic, Recurrent, or Refractory Squamous Cell Carcinoma of the Head and Neck
Clinical Cancer Research|2004
67 cit.

Indexing head and neck cancer studies Reagents

Citation data for reagents in this field is currently compiling.